Saturday, March 2, 2013

• [$$] Celgene Drug Results Fall Short of Earlier Trialat The Wall Street Journal (Sat, Mar 2)
• Celgene Psoriasis Drug Helped Third of Patients in Studyat Bloomberg (Sat, Mar 2)
• Celgene drug shown to be effective, safe in psoriasis trialat Reuters (Sat, Mar 2)

Friday, March 1, 2013

• Amgen Moves Up In Market Cap Rank, Passing Goldman Sachs Groupat Forbes (Fri, Mar 1)
• Are Biosimilar Delays News or Noise?at Motley Fool (Fri, Mar 1)
• Amgen To Present At The Cowen and Company 33rd Annual Health Care ConferencePR Newswire (Fri, Mar 1)

Thursday, February 28, 2013

• Why Is the Blockbuster Model Breaking?at Motley Fool (Thu, Feb 28)
• Eaton Declares Dividend Increase and 4 Stocks Riding 52-Week Highsat Wall St. Cheat Sheet (Thu, Feb 28)
• Zacks Bull and Bear of the Day Highlights: Lumber Liquidators Holdings, Weight Watchers International, Apple, Intel and AmgenZacks (Thu, Feb 28)

Wednesday, February 27, 2013

• High Court Allows Amgen Suitat The Wall Street Journal (Wed, Feb 27)
• Supreme Court Clips SEC's Wings In Gabelli Case; Defense Loses In Amgenat Forbes (Wed, Feb 27)
• 3 Stocks to Get on Your Watchlistat Motley Fool (Wed, Feb 27)
• 4 Drug Delivery Companies That Deliver For Investorsat Seeking Alpha (Wed, Feb 27)
• AMGEN INC Files SEC form 10-K, Annual ReportEDGAR Online (Wed, Feb 27)
• How Serious Is This News for Diabetes Drug Makers?at Motley Fool (Wed, Feb 27)
• Setback for AmgenZacks (Wed, Feb 27)
• Is AbbVie's Promising Cancer Drug Doomed?at Motley Fool (Wed, Feb 27)
• UPDATE 1-US Supreme Court rules against Amgen in class actionat Reuters (Wed, Feb 27)
• Securities-Fraud Suits Backed by High Court in Amgen Caseat Bloomberg (Wed, Feb 27)
• US high court rules against Amgen in class actionat Reuters (Wed, Feb 27)

Tuesday, February 26, 2013

• [$$] Biotech Drugs Still Won't Copyat The Wall Street Journal (Tue, Feb 26)
• [$$] Copies of Costly Biotech Drugs Face Delaysat The Wall Street Journal (Tue, Feb 26)
• 4 Cancer Treatments On The Way Upat Seeking Alpha (Tue, Feb 26)
• 4 Healthcare Stock Stories to Heal the Tuesday Bluesat Wall St. Cheat Sheet (Tue, Feb 26)
• FDA halts Amgen study after teen patient deathAP (Tue, Feb 26)

Add AMGN News to My Yahoo!